Concepedia

Beth Apsel

BA

Statistics

Publications

7

Citations

1.9K

H-Index

7

Active since

2003

Affiliations

University of California, San Francisco(Current)

Howard Hughes Medical Institute

New York University Langone Orthopedic Hospital

University of California, Berkeley

New York University

Beth Apsel is an author at University of California, San Francisco specializing in pharmacology, drug discovery, and medicinal chemistry.

Publications per year

2003–2009

7

Publications

7

Active-Site Inhibitors of mTOR Target Rapamycin-Resistant Outputs of mTORC1 and mTORC2

Morris E. Feldman, Beth Apsel, Aino Uotila et al. · PLoS Biology · 2009 · 1.1K citations · Full text

, , +17

Targeted polypharmacology: discovery of dual inhibitors of tyrosine and phosphoinositide kinases

Beth Apsel, Jimmy A. Blair, Beatriz González et al. · Nature Chemical Biology · 2008 · 439 citations · Full text

, , +14

Discovery of Trypanocidal Compounds by Whole Cell HTS of <i>Trypanosoma brucei</i>

Zachary B. Mackey, Arthur M. Baca, Jeremy P. Mallari et al. · Chemical Biology & Drug Design · 2006 · 106 citations · Full text

, , +17

Discovery of Drug-Resistant and Drug-Sensitizing Mutations in the Oncogenic PI3K Isoform p110α

Eli R. Zunder, Zachary A. Knight, Benjamin T. Houseman et al. · Cancer Cell · 2008 · 97 citations · Full text

, , +14

Cyclooxygenase-2-Derived E Prostaglandins Down-Regulate Matrix Metalloproteinase-1 Expression in Fibroblast-Like Synoviocytes via Inhibition of Extracellular Signal-Regulated Kinase Activation

Michael H. Pillinger, Sonia Tolani, Beth Apsel et al. · The Journal of Immunology · 2003 · 76 citations · Full text

, , +16

1–5 of 7